[stockyupydowny]

"If approved, MYMD-1 could become the first FDA-approved drug for sarcopenia, which causes patients to have a decline in muscle mass, among other symptoms.

MyMD Pharmaceuticals has already submitted and been approved for three Investigational New Drug Applications for MYMD-1. The company is advancing these clinical programs in chronic inflammatory conditions, including sarcopenia, rheumatoid arthritis and Hashimoto's disease, an often genetic disorder that causes inflammation of the thyroid gland.

[makinezmoney]

$MYMD: WOAAAAahhhhhhhhhhhh whatta pop. now $0.30


That was a big suprise from 0.22

NICEEEEEEEEeeeeeeeeeeeeeee



GO $MYMD

[stockyupydowny]

Solid News https://www.accesswire.com/820920/mymd-pharmaceuticals-releases-positive-clinical-trial-results-for-sarcopenia-treatment-drug

[stockyupydowny]

Buy out.... ?

[leifsmith]

I don't agree. My friends, employees, and I had direct experience with Anatabloc, a product of William's Star Scientific. The anatabine-citrate molecule was the real thing. The benefits were remarkable. People homebound with Crohn's disease were set free.

Now, there is evidence that the isomyosmine molecule, MYMD-1, is an improvement on anatabine-citrate.

The article linked should be treated with suspicion as a possible "hit piece". There were political currents involving Bob McDonnell's race for governor of Virginia. Williams got swept up in those currents and a letter was issued by the FDA (trust them? no) that destroyed his company and injured McDonnell.

The molecule being developed by Williams and his collaborators at Johns Hopkins is both a threat and an opportunity for major pharma companies currently earning large revenues from the sale of biologics.

MYMD-1 does everything the leading biologics (Enbrel, Humira) do, but better and without the serious side effects. They are biological sledge hammers, MYMD-1 is a jewelers hammer.

Ray Blanco's assessment is correct.

[B and B]

How many times how many message boards you going to post the same thing. I will add tomorrow Thanking you

[SeanVan]

This article must be read by every one.. Please share this.
This is not the first time Jonnie is doing this kind of fraud, its almost 4th time ... same kind, with same Chris Chapman...From Starscientific to Rockcreek Pharma to MyMD Pharma... Jonnie manipulated (with some crooks like Silveman) all these stocks into Penny stocks. He will never change and he is living on innocent investors blood. Very unethical, inhumane.... Its nothing but unpardonable financial crime if any investigation takes palce. Please note...

https://www.newsweek.com/2014/01/24/funny-money-man-behind-mcdonnells-fall-245100.html

[sheepsandgoats]

Take any profits you can by close tomorrow (best by close today). I believe shorts are closing and taking end year profits. Something to consider. Other thoughts for over 10M shares trading in less than 2 days, let's hear it.

[stockyupydowny]

Perhaps the buyout is taking place ..... this is well worth over $1 minimum ..... continuation into tomorrow?

[nathanial]

Going crazy after hours. Last trade 0.43. Huge volume.

[sheepsandgoats]

I'm inclined to agree.

[nathanial]

Nice dream!!!

[Brian581]

I haven’t, Is that what ur hearing

[sheepsandgoats]

Has anyone heard about rumored Amgen buyout of MYMD?

[leifsmith]

Science Direct article about isomyosmine, 2019

A four year old article about the molecule that is MYMD-1

https://www.sciencedirect.com/science/article/abs/pii/S0165572819302206

Abstract

Multiple sclerosis (MS) is an autoimmune disease that remains in need of effective therapies. Plant-derived medicines have appealing properties for the treatment of autoimmune diseases. MYMD-1 is a synthetic plant alkaloid that has been shown to ameliorate the course of autoimmune thyroiditis. The goal of the present study was to determine whether MYMD-1 would produce similar beneficial effects in a mouse model of MS, experimental autoimmune encephalomyelitis (EAE) induced by immunization with myelin oligodendrocyte glycoprotein. MYMD-1 improved the course of EAE and suppressed activation of effector T cells without causing global immunosuppression or toxicity. These results suggest that MYMD-1 may be of interest for evaluating for the treatment of autoimmune diseases.

[leifsmith]

Jonnie R Williams, MyMD: A patent of astonishing range just allowed

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20220339147

In paragraph [0012] note the breadth of coverage - far beyond "visual system"

Patent Application Publication ao) Pub. No.: US 2022/0339147 Al
Williams Pub. Date: Oct. 27,2022

METHOD OF TREATING DISEASES OF THE VISUAL SYSTEM

SUMMARY

[0009] In some aspects, a method of regulating oxidoreductase activity for treating an inflammation or age-related disorder comprises administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor. In some examples, the inflammation-related disorder is a parasitic infection or disease such as malaria. In other examples, the inflammation-related disorder is a bacterial infection or disease such as Lyme disease.

[0010] In other examples, a method of treating oxidative stress associated with an inflammation or age-related disor­der comprises administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceu­tically acceptable vehicle therefor.

[0011] In yet other examples, a method of reducing oxi­dative stress in an individual suffering from an inflammation or age-related disorder comprises administering to the indi­vidual a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.

[0012] In other aspects, a method of treating a disorder comprises administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, where the disorder is selected from the group consisting of infectious or parasitic diseases; neoplasms; diseases of the blood or blood-forming organs; diseases of the immune system; endocrine; nutri­tional or metabolic diseases; mental, behavioral or neurodevelopmental disorders; sleep-wake disorders; diseases of the nervous system; diseases of the visual system; diseases of the ear or mastoid process; diseases of the circulatory system; diseases of the respiratory system; diseases of the digestive system; diseases of the skin; diseases of the musculoskeletal system or connective tissue; diseases of the genitourinary system; conditions related to sexual health; pregnancy, childbirth or the puerperium; conditions origi­nating in the perinatal period; developmental anomalies; and injury ,poisoning or other consequences of external causes. In one example, a behavioral or neurodevelopmental disor­der is anxiety. In another example, a behavioral or neurode­velopmental disorder is depression.

***

A closely related patent:
Patent Application Publication (io)Pub. No.: US 2020/0338061 Al

Jonnie R Williams Pub.Date: Oct. 29,2020

METHODS OF REGULATING OXIDOREDUCTASE ACTIVITY FOR
TREATMENT OF INFLAMMATION AND AGE-RELATED DISORDERS

Applicant: MyMD Pharmaceuticals, Inc., Tampa, FL (US)

[Regis999]

Another day another new low on HUGE volume.

[Regis999]

Just amazing the selling volume as new lows are hit. Makes one wonder who is selling and why?

[leifsmith]

Entirely accidental. Making minor edits. I intended one post. Hub decided to make two posts. No idea why.

[sheepsandgoats]

IMHO,

Please repost intended content, and clarify your reason for repost.

Thank you,

Sheepsandgoats

[leifsmith]

No idea why post #394 was posted by iHUBs software.

The correct version of the post (almost identical) is post #393, which I edited a few times.

Then iHUB decided to post the unedited version as #394.

[leifsmith]

Sometimes stock price is based on incomplete information.

Take a look at what happened to Tempest Pharmaceuticals (TPST) on 11 Oct 2023.

Information previously unknown to market participants became known. On that day the stock opened at $0.17, moved up on wild speculation to $9.80, and closed at $3.60. Its current price is $3.76.

A stock chart will show a pattern of steady decline that resembles what we are seeing for MYMD.

But, nothing about TPST can be taken to predict anything about the future of MYMD.

TPST does illustrate that sudden introduction of new information can have a radical effect on stock price.

Such may happen with MYMD. My understanding of the science suggests to me that it's possible. Ray may have his day.

[leifsmith]

Sometimes stock price is based on incomplete information.

Take a look at what happened to Tempest Pharmaceuticals (TPST) on 11 Oct 2023.

Information previously unknown to market participants became known. On that day the stock opened at $0.17, moved up on wild speculation to $9.80, and closed at $3.60. Its current price is $3.76.

A stock chart will show a pattern of steady decline that resembles what we are seeing for MYMD.

But, nothing about TPST can be taken to predict anything about the future of MYMD.

TPST does illustrate that sudden introduction of new information can have a radical effect on stock price.

Such may happen with MYMD. My understanding of the science suggests to me that it's possible.

Ray Blanco may have his day.

[Regis999]

Business Strategy ? How about judging such based upon the market price?

[leifsmith]

Ray Blanco is correct about the science. Credible results from trials can make that clear, and I think they will do that. However, the quality of business strategy is not something I can judge.

[Regis999]

The 2023 Turkey of the Year award goes…
Frank Curio and Ray Blanco touting MyMD Pharmaceuticals (MYMD), and a couple folks pitching Plug Power (PLUG) weren’t very far behind.

[Regis999]

New 52 Week Low--huge selling volume

[leifsmith]

Last trade of the day: 1,387,425 shares.

[leifsmith]

The link you posted leads to something good - not obvious from the url only:

"Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies
BioTalk with Rich Bendis"

https://podcasts.apple.com/us/podcast/revolutionizing-autoimmune-medicine-mymd-pharmaceuticals/id1274273731

Thanks!

[B and B]

Great podcast https://apple.co/46wCAsf

[B and B]

Great podcast https://apple.co/46wCAsf

[leifsmith]

News Release Today

MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain

https://ir.mymd.com/news-events/press-releases/detail/54/mymd-announces-preclinical-study-results-showing-novel

[saxonia40271]

Public companies generally can’t drop bombshells in private settings. A common solution is to distribute the information to the public on the same day, preferably before the presentation. Without such a document, you can assume that they revealed nothing new.

[Regis999]

Call Investors:
Robert Schatz
[phone]
[e-mail]

[deast]

Does anyone know what Chapman said in his presentation at the Bio Future 2023? Maybe it's a closely guarded secret.

[Monksdream]

MYMD new 52 week low

[leifsmith]

PR: new data on Potential TNF-a Market Disrupter

MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-a Market Disrupter, at BioFuture 2023

https://www.businesswire.com/news/home/20231004139695/en/

[Monksdream]

MYMD new 52 week low

[Regis999]

The sad part of all this Anatabloc was by itself a great product. IMHO just having Williams involved tainted it and doomed it for failure.

Just look under the hood of MYMD. IMHO a facade of deception. Why follow the same script?

[SeanVan]

The newsweek magazine published 9 years ago about the fraudulent Founder of MyMD Pharma Jonnie Williams , and previous founder of failed companies : Star Scientific & Rockcreek pharma.
Every one must read this article.. He is called as penny stock hoader... repeating same after 15 years..
https://www.newsweek.com/2014/01/24/funny-money-man-behind-mcdonnells-fall-245100.html

[Monksdream]

MYMD new 52 week low

[Monksdream]

MYMD new 52 week low

[Regis999]

Same story all the time. You would think they would learn something from the past. Smoke and Mirrors.

[Monksdream]

MYMD new 52 week low

[SeanVan]

Sounds a fraudulent company, these same folks failed and manipulated same "small molecule( Pre version of MyMD-1 as Anatabloc)" using Star scientific and Rockcreek pharma and looted common man money.. Very dangerous manipulation by owner: Jonnie Williams. There might be a class action suit by investors soon.